Schedule 13D ownership disclosure

Keenova Therapeutics PLC

Common Stock, par value $0.01 per share · CUSIP: G5890A102

Event date: 2025-03-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Hein Park Capital Management LPReported CIK 0001826937

    Shares: 1,914,673 · Class: 9.69%

  • Hein Park Capital Management GP LLC

    Shares: 1,914,673 · Class: 9.69%

  • Courtney W. Carson

    Shares: 1,914,673 · Class: 9.69%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-25-000425
Form type
SCHEDULE 13D/A
Filer
Hein Park Capital Management LP
CIK
CIK 1826937
Filed
Mar 17, 2025
Reporting period
Mar 13, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub